Niagen Bioscience (NAGE) EPS (Basic) Growth (5y) (2016 - 2026)
Niagen Bioscience (NAGE) EPS (Basic) Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Niagen Bioscience |
269.32 Mn |
202.77 Mn |
19.98 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
21.67% |
| Dec 31, 2025 |
20.11% |
| Sep 30, 2025 |
23.36% |
| Jun 30, 2025 |
23.16% |
| Mar 31, 2025 |
21.98% |
| Dec 31, 2024 |
21.06% |
| Sep 30, 2024 |
16.72% |
| Jun 30, 2024 |
73.06% |
| Mar 31, 2024 |
41.82% |
| Dec 31, 2023 |
14.99% |
| Sep 30, 2023 |
42.57% |
| Jun 30, 2023 |
27.52% |
| Mar 31, 2023 |
27.52% |
| Dec 31, 2022 |
34.82% |
| Sep 30, 2022 |
-17.08% |
| Jun 30, 2022 |
-5.15% |
| Mar 31, 2022 |
-17.08% |
| Dec 31, 2021 |
-3.13% |
| Sep 30, 2021 |
-34.08% |
| Jun 30, 2021 |
-75.37% |
